RSV Vaccine Research and Development Technology Roadmap
This report provides a strategic framework for respiratory syncytial virus (RSV) vaccine development. It identifies priority activities in four key categories—research, vaccine development, key capacities, and policy and delivery—that need to be undertaken in order to develop and license high-quality, safe, and effective RSV vaccines that prevent severe disease and death in young infants and children less than five years of age and are available and affordable for use in low- and middle-income countries.
Author: World Health Organization
» Download file (English)
650 KB PDF (Located at apps.who.int)
Resource types: Report
Diseases/vaccines: Respiratory syncytial virus (RSV)